key: cord-0931759-k2tqqeud
authors: Bhargava, Shashank; McKeever, Charles; Kroumpouzos, George
title: Impact of covid-19 pandemic on dermatology practice: results of a web-based, global survey
date: 2020-10-12
journal: Int J Womens Dermatol
DOI: 10.1016/j.ijwd.2020.09.010
sha: 407cef68dd507af9257cf71d3ec08fc5905a8ade
doc_id: 931759
cord_uid: k2tqqeud

BACKGROUND: The spectrum and magnitude of changes in dermatology practice induced by the COVID-19 pandemic have not been adequately studied. OBJECTIVES: To assess immediate and long-term effects of the pandemic on dermatology practice on a large scale, including the clinical activity of participant, frequency and types of procedures used, and teledermatology (TD) use. METHODS: This web-based, global survey included 733 dermatologists. Primary outcomes are percentages of responders providing in-person consultations, hospital service, and TD, and doing procedures. Also, factors in logistic regression models that may influence the Odds Ratio (OR) for TD use during pandemic and for future use. RESULTS: The percentages of responders providing in-person consultations (46.6% vs 100% before), and hospital service (27% vs 52.8% before), and doing procedures (25.6% vs 100% before) decreased while practicing TD increased three-fold (75.2% vs 26.1% before) during pandemic (P < .001 for each). Practice location was associated with TD use during the pandemic and with its expected use in the future (P < .001 for both), with North American responders indicating the highest use. TD use during the pandemic showed a positive correlation with TD use before, performing procedures and, more specifically, with biopsies of suspicious pigmented lesions during pandemic (P < .001 for each). TD use before pandemic was the most powerful predictor of TD use during pandemic (OR, 16.47 [95% CI, 7.12-38.06]). More than two thirds (68.6%) of participants expect to use TD in the future. The factor with the largest increase in OR on the expectation of future TD use was >1,000 COVID-19 cases in the country (OR, 3.80 [95% CI, 2.33-6.21]). CONCLUSIONS: This survey indicates a profound immediate effect of the pandemic on dermatology practice. The pandemic appears to have substantially contributed to an increased use of TD in the long-run.

113 Participants could access the survey via a link that was provided. The survey instrument was 114 disseminated twice, the data collection period was extended, and reminder messages were sent to 115 increase participation. Two questions relevant to numbers of biopsies performed and postponed during 116 pandemic were added to instrument before the second dissemination. This was an anonymous survey, 117 there was no process of data linkage, and neither recording nor dissemination generated identifiable 118 information. 7 136 Logistic regression models were generated for each of the following binary dependent variables: 'TD use 137 during pandemic' and 'future TD use'. Models were created through forward selection in which 138 candidate independent variables found to be associated with the outcome variable at P <= .0001 were 139 entered in order from the smallest to larger P values. Once entered into the model variables that had OR 140 estimated at P > 0.05 were dropped. Nested models were compared using the log likelihood test, and 141 those that were not nested were compared on model specification, Akaike information criterion, 142 Homor-Lemelshow goodness-of-fit, variance inflation factor, tolerance and condition index (Tolles and 143 Meurer, 2016). When variables with more than 3 categories were found to fail the retention criterion or 144 to have categories that did not differ significantly in their estimated OR, they were re-coded into binary 145 variables which were then tested for inclusion. In the final best models, the odds ratio (OR) that the 146 dependent variable = 1 is given by the baseline OR (the value of _cons) multiplied by the OR of each 147 independent variable when they are = 1. Statistical analysis was performed using Stata 15. (Table 5) . A median 5 biopsies per week (IQR, 3-20) were postponed. Neither the numbers of biopsies 232 per week performed nor those postponed were associated with TD use. The North America group had 233 both a lower mean for biopsies taken (4.95) and a higher mean for biopsies postponed (21.2) when 234 compared to a US group (7.7 and 10.7, respectively) in a study that was performed during pandemic 235 (Litchman and Rigel, 2020) . This is possibly due to this data having been collected at an earlier stage in 14 291 bias we sent reminder messages to invited participants on weekends. Recall biases cannot be excluded 292 but the large sample size and representative distribution possibly diminished them. No-response biases 293 cannot be excluded but access to social media and demographics did not differ between the groups of 294 responders and non-responders. 

8% of responders 161 provided only TD, 37.3% a combination of TD and in-person consultation, 9.3% solely in-person 162 consultations, and 15.6% stopped clinical activity. Of those that stopped working, 79.8% were located in 163 geographic locations on total lockdown (P < .001 for partial vs total lockdown). More than one fourth of 164 responders were providing hospital service (27% vs 52.8% before, P <.001). The majority of participants 165

Excision was even less common (10.1%), and only 7.4% of participants performing 173 procedures were doing cosmetic procedures. Median (IQR) value for biopsies of suspicious pigmented 174 lesions taken per week by dermatologists providing-face-to face consultations during pandemic (n=220)

The mean values for biopsies taken (n=88) and postponed (n=94) in the North America

More than two thirds of participants (68.6%) expect to practice TD in the 184 future, the majority (79.9%) as part of their regular practice. Responders anticipated more consultations 185 in the future than during the pandemic (P = .002 for >20 consultations/wk). Whatsapp was the most 186 common platform not only in the total of participants (Table 3) but across all continents as well (Europe, 187 62.4%; Asia 62.6%; North America 39.4%; Central/South America, 36.7%)

Practice location was associated with TD use during the pandemic 195 and with its expected use in the future (P < .001 for both), with North American responders indicating 196 the highest use. TD use during the pandemic showed a positive correlation with TD use before, 197 performing procedures and, more specifically, with biopsies of suspicious pigmented lesions during 198 pandemic (P < .001 for each). Future TD use showed a positive correlation with the number of patients 199 seen per week before, and with TD use before and during the pandemic (P < .001 for each)

Other 206 factors increasing the same OR were TD use before, and using TD for both follow up and new patients, in in-person consultations and non-emergency procedures, and a remarkable increase in TD 213 use (Wollina, 2020, Litchman and Rigel

Only one fourth of dermatologists continued performing procedures during the pandemic

Biopsy was the most common followed by Mohs surgery. Excision was performed less often than Mohs 221 surgery. This possibly indicates a priority on treating high-risk tumors, ie, performing Mohs surgery for

3%) of non-reimbursement, more than two thirds of responders (68.6%) 270 expect to use TD in the future, the majority (68.6%) as part of their regular practice

Other 279 factors in the logistic model that increased the OR for future TD use were TD use before, and TD use for 280 both follow up and new patients, and video visits during pandemic. Dermatologists that used TD for new 281 patients during the pandemic could have accommodated more appointment requests from them, and 282 video TD consultations may offer an advantage in physician-patient interaction compared to other TD 283 forms (eg, phone call)

Management of 324 primary skin cancer during a pandemic: multidisciplinary recommendations

Protection comes at a cost: doctor's life inside personal 327 protection equipment

Global impact on dermatology 329 practice due to COVID-19

Employing dermatologists on the frontline against 331 COVID-19: all hands on deck

Virtual dermatology: a COVID-19 update

British Association of Dermatologists and British Society for Dermatological Surgery. COVID-19 -skin pandemic

Which dermatology patients attend to dermatology outpatient 339 clinics during the SARS-CoV-2 outbreak in Turkey and what happened to them?

A general introduction to adjustment for multiple comparisons

What are we doing in the dermatology outpatient department amidst the 344 raging of the 2019 novel coronavirus

Recommendations on dermatologic 346 surgery during the COVID-19 pandemic

Did Whatsapp® reveal a new cutaneous COVID-19 manifestation? 348

Fair Allocation of Scarce Medical 351 Resources in the Time of Covid-19

COVID-19 and 353 dermatology: a comprehensive guide for dermatologists

COVID 19 and its impact on cosmetic dermatology

Online ahead of print

Dermatologists and SARS-CoV-2: the impact of the pandemic on 358 daily practice

Perspectives on the 360 recommendations for skin cancer management during the COVID-19 pandemic

Use of face masks in dermatology department during the 363 COVID-19 outbreak

Update on COVID-19 effects on dermatology specialty 365

Safety measures in dermatology help 367 minimize spread of COVID-19

Evaluating the dermatology communities' public health response to COVID-19 369

Teledermatology in the wake of COVID-19: Advantages and challenges 371 to continued care in a time of disarray

Analysis of dermatology-related search engine trends during the COVID-19 374 pandemic: Implications for patient demand for outpatient services and telehealth

WhatsApp messenger as a teledermatology tool during coronavirus disease 379 (COVID-19): from bedside to phone-side

Changing paradigms of dermatology practice in developing nations in the 381 shadow of COVID-19: lessons learnt from the pandemic

Dermatology practices as vectors for COVID-19 transmission: A call 384 for immediate cessation of nonemergent dermatology visits

Telehealth: helping your patients and practice survive and 386 thrive during the COVID-19 crisis with rapid quality implementation

The immediate impact of COVID-19 on US dermatology practices

How Dermatologists Can Learn and Contribute at the Leading 391 Edge of the COVID-19 Global Pandemic

global preparedness against COVID-19: we must 395 leverage the power of digital health

Patient and provider satisfaction with 397 teledermatology

A systematic review of satisfaction with teledermatology

An assessment of United States dermatology practices during 401 the COVID-19 outbreak

Advisory statement for non-melanoma skin cancer care 403 during the COVID-19 pandemic

National Comprehensive Cancer Network. Short-term recommendations for cutaneous melanoma 406 management during COVID-19 pandemic

Global coronavirus pandemic (2019-nCOV): implication for 409 an Italian medium size dermatological clinic of a II level hospital

Restructuring an academic dermatology practice during the COVID-19 412 pandemic

Emergency management for preventing and controlling 414 nosocomial infection of the 2019 novel coronavirus: implications for the dermatology department

Evaluation of dermatology consultations in the era of COVID-417 19

Logistic regression: relating patient characteristics to outcomes

Teledermatology: a useful tool to fight COVID-19

Challenges of COVID-19 pandemic for dermatology

Consensus of Chinese experts on protection of skin 425 and mucous membrane barrier for health-care workers fighting against coronavirus disease

Dermatology staff participate in fight against Covid-19 in China

This web-based, global survey of dermatologists showed a decrease in in-person 474 consultations, hospital service, and procedures, a 3-fold increase in teledermatology use, 475 and a shortage in PPE in the healthcare system

 The number of COVID-19 cases in participant's country was the most important prognostic 477 factor of future teledermatology use

 The pandemic had immediate impact on dermatology practice